Hubei Cancer Hospital /ID# 260506

Wuhan, Hubei 430079

0 studies enrolling now · 1 studies all time

What they study most

Follicular Lymphoma (FL)

Studies at this site

• Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma — Running, not enrolling